A new pharmaceutical plant is planned to be built in Almaty with investments of more than ₸39 billion. The project aims to expand drug production and deepen the localization of international developments within the country. The first production launches are scheduled for 2029.
A new pharmaceutical plant is planned to be built in Almaty with investments of more than ₸39 billion. The project aims to expand drug production and deepen the localization of international developments within the country. The first production launches are scheduled for 2029.
The government of Kazakhstan has approved investment agreements between the Ministry of Healthcare and four pharmaceutical companies. The projects, with a total volume of ₸173 billion, aim to localize the production of 356 types of medicines. The sites are located in Almaty and the Almaty and Turkestan regions.
AETEK® is a registered word mark of AETEK GmbH, German Patent and Trade Mark Office (DPMA), Reg. No. 30 2023 202 928 (expires 31 Jan. 2033).
View registration certificate (PDF)
Legal Entity Identifier (LEI) 391200MNLJ2E0R0I6V98, issued 16 Aug. 2021 by Bundesanzeiger Verlag.
View in GLEIF register
AETEK company flyer 2026 – Business Development as a Service, in English.
View flyer
AETEK Business Model Disclosure (pre-NDA, one page, October 2026), in English.
Download PDF